Ozempic face describes facial volume loss and skin changes from rapid weight loss with GLP-1 medications like Ozempic, Wegovy and Mounjaro
Whilst the GLP-1 receptor has far-reaching downstream signalling pathways, its expressed predominantly in the pancreas (with lower level expression in the gastrointestinal tract, muscles, and brain), meaning that, mechanistically, this organ is also likely to play a role in the relationship between Semaglutide and cancer
Conversely, they induce the downstream signaling pathways involving protein kinases of the MAPK and phosphoinositide 3-kinase (PI3K) cascades [12]
Within the past two years, GLP-1 agonists, such as semaglutide and tirzepatide, have emerged as effective treatments in the fight against obesity and weight loss resistance
Nausea is typically the most common, however, vomiting, diarrhea and constipation are all vying for a close second